Unknown

Dataset Information

0

Pharmacogenomics of sickle cell disease: steps toward personalized medicine.


ABSTRACT: Sickle cell disease (SCD) is a monogenetic disease but has a wide range of phenotypic expressions. Some of these differences in phenotype can be explained by genetic polymorphisms in the human globin gene. These polymorphisms can result in different responses to typical treatment, sometimes leading to inadequate therapeutics. Research is revealing more polymorphisms, and therefore, new targets for intervention to improve outcomes in SCD. This area of pharmacogenomics is continuing to develop. We provide a brief review of the current literature on pharmacogenomics in SCD and possible targets for intervention.

SUBMITTER: Husain M 

PROVIDER: S-EPMC5656342 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pharmacogenomics of sickle cell disease: steps toward personalized medicine.

Husain Marium M   Hartman Amber D AD   Desai Payal P  

Pharmacogenomics and personalized medicine 20171019


Sickle cell disease (SCD) is a monogenetic disease but has a wide range of phenotypic expressions. Some of these differences in phenotype can be explained by genetic polymorphisms in the human globin gene. These polymorphisms can result in different responses to typical treatment, sometimes leading to inadequate therapeutics. Research is revealing more polymorphisms, and therefore, new targets for intervention to improve outcomes in SCD. This area of pharmacogenomics is continuing to develop. We  ...[more]

Similar Datasets

| S-EPMC3513203 | biostudies-literature
| S-EPMC3513204 | biostudies-literature
| S-EPMC3513202 | biostudies-literature
| S-EPMC9325258 | biostudies-literature
| S-EPMC6463228 | biostudies-literature
| S-EPMC4920853 | biostudies-other
| S-EPMC3660037 | biostudies-literature
| S-EPMC3513214 | biostudies-literature
| S-EPMC9326582 | biostudies-literature
| S-EPMC5997834 | biostudies-other